{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-063479","form_type":"8-K","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2025-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.015916+00:00","generated_at":"2026-05-18T06:43:21.020275+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OS Therapies closes $4.2M warrant exercise inducement; extends cash runway to 2026","bullets":["Raised $4.2M gross from exercise of 3.8M existing warrants at $1.12/share; issued new warrants at $3.00/share.","Cash runway extended through 2026, beyond Sept 30, 2026 PRV sunset date for rare pediatric diseases.","Proceeds to support OST-HER2 regulatory efforts for osteosarcoma, advance OS Animal Health, close OST-504 prostate cancer study, and initiate AI-driven ADC modeling.","CEO Paul Romness highlighted End of Phase 2 meeting with FDA and Scientific Advice Meetings in UK/Europe.","New warrants exercisable for 5 years at $3.00/share; forced exercise if stock hits 300% of exercise price for 20 consecutive trading days."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-063479","json":"https://secwatch.observer/filing/0001213900-25-063479.json","markdown":"https://secwatch.observer/filing/0001213900-25-063479.md","text":"https://secwatch.observer/filing/0001213900-25-063479.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025063479/0001213900-25-063479-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025063479/ea0248754-8k_ostherap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:43:21.020275+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}